{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:49:42Z","timestamp":1784044182150,"version":"3.55.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"DOI":"10.1093\/humrep\/dei165","type":"journal-article","created":{"date-parts":[[2005,7,9]],"date-time":"2005-07-09T04:00:45Z","timestamp":1120881645000},"page":"3152-3156","source":"Crossref","is-referenced-by-count":22,"title":["Cell-free fetal DNA levels in pregnancies conceived by IVF"],"prefix":"10.1093","volume":"20","author":[{"given":"Phillip D.","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geralyn M.","family":"Lambert-Messerlian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob A.","family":"Canick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana W.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirby L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,7,8]]},"reference":[{"key":"key\n\t\t\t\t20171012102617_BARKAI-ET-AL-1996","doi-asserted-by":"crossref","unstructured":"Barkai G , Goldman B, Ries L, Chaki R, Dor J and Cuckle H (1996) Down\u2019s syndrome screening marker levels following assisted reproduction. Prenat Diagn16, 1111\u20131114.","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1111::AID-PD998>3.0.CO;2-X"},{"key":"key\n\t\t\t\t20171012102617_BIANCHI-2004","unstructured":"Bianchi DW (2004) Circulating fetal DNA: its origin and diagnosis potential. A review. Placenta25, S93\u2013S101."},{"key":"key\n\t\t\t\t20171012102617_FARINA-ET-AL-2003","doi-asserted-by":"crossref","unstructured":"Farina A , LeShane ES, Lambert-Messerlian GM, Canick JA, Lee T, Neveux LM, Palomaki GE and Bianchi DW (2003) Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem49, 239\u2013242.","DOI":"10.1373\/49.2.239"},{"key":"key\n\t\t\t\t20171012102617_FRISHMAN-ET-AL-1997","doi-asserted-by":"crossref","unstructured":"Frishman GN , Canick JA, Hogan JW, Hackett RJ, Kellner LH and Saller DN, Jr. (1997) Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies. Obstet Gynecol90, 98\u2013101.","DOI":"10.1016\/S0029-7844(97)00139-7"},{"key":"key\n\t\t\t\t20171012102617_HEINONEN-ET-AL-1996","doi-asserted-by":"crossref","unstructured":"Heinonen S , Ryynanen M, Kirkinen P, Hippelainen M and Saarikoski S (1996) Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down\u2019s syndrome screening. Fertil Steril66, 398\u2013403.","DOI":"10.1016\/S0015-0282(16)58508-2"},{"key":"key\n\t\t\t\t20171012102617_JOHNSON-ET-AL-2004","doi-asserted-by":"crossref","unstructured":"Johnson KL , Dukes KA, Vidaver J, LeShane ES, Ramirez I, Weber WD, Bischoff FZ, Hahn S, Sharma A, Dang DX et al. (2004) Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR. Clin Chem50, 516\u2013521.","DOI":"10.1373\/clinchem.2003.024380"},{"key":"key\n\t\t\t\t20171012102617_LAM-ET-AL-1999","doi-asserted-by":"crossref","unstructured":"Lam YH , Yeung WS, Tang MH, Ng EH, So WW and Ho PC (1999) Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in-vitro fertilization. Hum Reprod14, 2120\u20132123.","DOI":"10.1093\/humrep\/14.8.2120"},{"key":"key\n\t\t\t\t20171012102617_LIAO-ET-AL-2001","doi-asserted-by":"crossref","unstructured":"Liao AW , Heath V, Kametas N, Spencer K and Nicolaides KH (2001) First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod16, 1501\u20131504.","DOI":"10.1093\/humrep\/16.7.1501"},{"key":"key\n\t\t\t\t20171012102617_LO-1997","unstructured":"Lo YM , Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW and Wainscoat JS (1997) Presence of fetal DNA in maternal plasma and serum. Lancet350, 485\u2013487."},{"key":"key\n\t\t\t\t20171012102617_LO-ET-AL-1998","doi-asserted-by":"crossref","unstructured":"Lo YM , Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM and Hjelm NM (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet62, 768\u2013775.","DOI":"10.1086\/301800"},{"key":"key\n\t\t\t\t20171012102617_LO-ET-AL-1999","unstructured":"Lo YM , Lau TK, Zhang J, Leung TN, Chang AM, Hjelm NM, Elmes RS and Bianchi DW (1999) Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem45, 1747\u20131751."},{"key":"key\n\t\t\t\t20171012102617_MAYMON-2002","doi-asserted-by":"crossref","unstructured":"Maymon R and Shulman A (2002) Serial first- and second-trimester Down\u2019s syndrome screening tests among IVF-versus naturally-conceived singletons. Hum Reprod17, 1081\u20131085.","DOI":"10.1093\/humrep\/17.4.1081"},{"key":"key\n\t\t\t\t20171012102617_MULLER-ET-AL-2003","doi-asserted-by":"crossref","unstructured":"Muller F , Dreux S, Lemeur A, Sault C, Desgres J, Bernard MA, Giorgetti C, Lemay C, Mirallie S, Beauchet A et al. (2003) Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome. Prenat Diagn23, 1073\u20131076.","DOI":"10.1002\/pd.756"},{"key":"key\n\t\t\t\t20171012102617_OHASHI-2002","doi-asserted-by":"crossref","unstructured":"Ohashi Y , Miharu N, Honda H, Samura O and Ohama K (2002) Correlation of fetal DNA and human chorionic gonadotropin concentrations in second-trimester maternal serum. Clin Chem48, 386\u2013388.","DOI":"10.1093\/clinchem\/48.2.386"},{"key":"key\n\t\t\t\t20171012102617_RIBBERT-1996","doi-asserted-by":"crossref","unstructured":"Ribbert LS , Kornman LH, De Wolf BT, Simons AH, Jansen CA, Beekhuis JR and Mantingh A (1996) Maternal serum screening for fetal Down syndrome in IVF pregnancies. Prenat Diagn, 16, 35\u201338.","DOI":"10.1002\/(SICI)1097-0223(199601)16:1<35::AID-PD805>3.0.CO;2-9"},{"key":"key\n\t\t\t\t20171012102617_SMID-ET-AL-2003","doi-asserted-by":"crossref","unstructured":"Smid M , Galbiati S, Vassallo A, Gambini D, Ferrari A, Restagno G, Viora E, Pagliano M, Calza S, Ferrari M et al. (2003) Fetal DNA in maternal plasma in twin pregnancies. Clin Chem49,1526\u20131528.","DOI":"10.1373\/49.9.1526"},{"key":"key\n\t\t\t\t20171012102617_WALD-ET-AL-1997","doi-asserted-by":"crossref","unstructured":"Wald NJ , Kennard A, Hackshaw A and McGuire A (1997) Antenatal screening for Down\u2019s syndrome. J Med Screen4, 181\u2013246.","DOI":"10.1177\/096914139700400402"},{"key":"key\n\t\t\t\t20171012102617_WALD-ET-AL-1999","doi-asserted-by":"crossref","unstructured":"Wald NJ , White N, Morris JK, Huttly WJ and Canick JA (1999) Serum markers for Down\u2019s syndrome in women who have had in vitro fertilisation: implications for antenatal screening. Br J Obstet Gynaecol106, 1304\u20131306.","DOI":"10.1111\/j.1471-0528.1999.tb08186.x"},{"key":"key\n\t\t\t\t20171012102617_WALD-2003","doi-asserted-by":"crossref","unstructured":"Wald NJ , Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM and SURUSS Research Group (2003) First and second trimester antenatal screening for Down\u2019s syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess7, 1\u201377.","DOI":"10.3310\/hta7110"},{"key":"key\n\t\t\t\t20171012102617_WATAGANARA-AND-LESHANEES-2003","doi-asserted-by":"crossref","unstructured":"Wataganara T , LeShane ES, Farina A, Messerlian GM, Lee T, Canick JA and Bianchi DW (2003) Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18. Hum Genet112, 204\u2013208.","DOI":"10.1007\/s00439-002-0853-9"},{"key":"key\n\t\t\t\t20171012102617_WATAGANARA-ET-AL-2005","doi-asserted-by":"crossref","unstructured":"Wataganara T , Metzenbauer M, Peter I, Johnson KL and Bianchi DW (2005) Placental volume, as measured by three-dimensional sonography, and levels of maternal plasma cell-free fetal DNA. Am J Obstet Gynecol. In press.","DOI":"10.1016\/j.ajog.2004.12.015"},{"key":"key\n\t\t\t\t20171012102617_ZHONG-ET-AL-2000","doi-asserted-by":"crossref","unstructured":"Zhong XY , Burk MR, Troeger C, Jackson LR, Holzgreve W and Hahn S (2000) Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn20, 795\u2013798.","DOI":"10.1002\/1097-0223(200010)20:10<795::AID-PD897>3.0.CO;2-P"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/20\/11\/3152\/9543062\/dei165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T05:58:07Z","timestamp":1586325487000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/20\/11\/3152\/2913671\/Cellfree-fetal-DNA-levels-in-pregnancies-conceived"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,8]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2005,7,8]]},"published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dei165","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,11]]},"published":{"date-parts":[[2005,7,8]]}}}